AQA
BIIB icon

Alpha Quant Advisors’s Biogen BIIB Stock Holding History

Alpha Quant Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$822K Sell
3,476
-1,050
-23% -$331K 0.82% 55
2018
Q4 		$1.36M Buy
+4,526
New +$1.44M 1.41% 14

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Quant Advisors's BIIB Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Biogen (BIIB) stake by 23% in Q1 2019, selling an estimated $331K and leaving 3,476 shares worth $822K. The position accounts for 0.82% of the portfolio, ranked #55.

Alpha Quant Advisors first reported a position in BIIB in Q4 2018 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Alpha Quant Advisors held 3,476 shares of Biogen worth $822K as of Q1 2019.
  • Alpha Quant Advisors sold 1,050 Biogen shares in Q1 2019, an estimated $331K.
  • Biogen made up 0.82% of Alpha Quant Advisors's portfolio in Q1 2019, its #55 holding.
  • Alpha Quant Advisors first reported a position in Biogen in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Biogen position peaked at $1.36M in Q4 2018.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.